These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Variation in angiotensin-converting enzyme (ACE) inhibitor affinity at two binding sites on rat pulmonary ACE: influence on bradykinin hydrolysis. Perich RB; Jackson B; Johnston CI Clin Exp Pharmacol Physiol; 1992 May; 19(5):353-7. PubMed ID: 1325885 [TBL] [Abstract][Full Text] [Related]
48. Development of angiotensin-converting enzyme in fetal rat lungs. Wallace KB; Bailie MD; Hook JB Am J Physiol; 1979 Jan; 236(1):R57-60. PubMed ID: 219709 [TBL] [Abstract][Full Text] [Related]
49. Propofol attenuates endotoxin-induced endothelial cell injury, angiotensin-converting enzyme shedding, and lung edema. Votta-Velis EG; Minshall RD; Visintine DJ; Castellon M; Balyasnikova IV Anesth Analg; 2007 Nov; 105(5):1363-70, table of contents. PubMed ID: 17959967 [TBL] [Abstract][Full Text] [Related]
50. Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline. Azizi M; Junot C; Ezan E; Ménard J Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1066-9. PubMed ID: 11903317 [TBL] [Abstract][Full Text] [Related]
51. Structure-function analysis of angiotensin-converting enzyme inhibitors as modifiers of radiation-induced pulmonary endothelial dysfunction in rats. Ward WF; Molteni A; Kim YT; Ts'ao C Br J Radiol; 1989 Apr; 62(736):348-54. PubMed ID: 2540864 [TBL] [Abstract][Full Text] [Related]
52. Immunotargeting of the pulmonary endothelium via angiotensin-converting-enzyme in isolated ventilated and perfused human lung. Nowak K; Kölbel HC; Metzger RP; Hanusch C; Frohnmeyer M; Hohenberger P; Danilov SM Adv Exp Med Biol; 2013; 756():203-12. PubMed ID: 22836637 [TBL] [Abstract][Full Text] [Related]
53. Resolution of impaired pulmonary function and pulmonary hypertension after phorbol ester administration in rabbits. Havill AM; Riggs D; Pitt BR; Gillis CN Am Rev Respir Dis; 1989 Sep; 140(3):782-8. PubMed ID: 2551205 [TBL] [Abstract][Full Text] [Related]
54. Quantification of pulmonary capillary endothelium-bound angiotensin converting enzyme inhibition in man. Cziraki A; Horvath I; Rubin JW; Theodorakis M; Catravas JD Gen Pharmacol; 2000 Oct; 35(4):213-8. PubMed ID: 11827728 [TBL] [Abstract][Full Text] [Related]
55. Effects of acid-base imbalance on pulmonary angiotensin-converting enzyme in vivo. Toivonen HJ; Catravas JD J Appl Physiol (1985); 1987 Oct; 63(4):1629-37. PubMed ID: 2826379 [TBL] [Abstract][Full Text] [Related]
57. Functional assessment of the pulmonary microcirculation during postnatal development. Lister G; Kopf GS; Pitt BR Pediatr Pharmacol (New York); 1984; 4(2):85-99. PubMed ID: 6091021 [TBL] [Abstract][Full Text] [Related]
58. Angiotensin converting enzyme concentrations in the lung lavage of normal rabbits and rabbits treated with nitrogen mustard exposed to hyperoxia. Shasby DM; Shasby SS; Bowman CM; Fox RB; Harada RM; Tate RM; Repine JE Am Rev Respir Dis; 1981 Aug; 124(2):202-3. PubMed ID: 6266299 [TBL] [Abstract][Full Text] [Related]
59. A new approach to the investigation of oxidative injury to the pulmonary endothelium: use of angiotensin-converting enzyme as a marker. Muzykantov VR; Danilov SM Biomed Sci; 1991; 2(1):11-21. PubMed ID: 1655078 [TBL] [Abstract][Full Text] [Related]
60. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I. Michaud A; Williams TA; Chauvet MT; Corvol P Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]